If a patient presented to the Emergency Department twice during the data collection period, the patient's data was included only for the first visit, and the subsequent visits were not included. An informed consent was taken from all the patients. This study was approved by the Institutional Review Board of National Academy of Medical Sciences. All the required data were collected by filling up a questionnaire, and the data were analyzed using Microsoft Excel 2007 and Statistical Package for Social Sciences (SPSS) version 20. Descriptive statistics were calculated using mean and standard deviation.
Results
A total of 591 consecutive patients were evaluated. The age of the patients varied from 12 to 94 years with a mean age of 56.48 ±19.44 years. There were 271 male patients (45.9%) and 320 female patients (54.1%) as shown in Table 1 . Among these patients with HF, 31.9% patients were on an antiplatelet agent, 18.6% on a statin, 30.1% on an angiotensin converting enzyme inhibitor (ACEi) or an angiotensin receptor blocker (ARB), 20.5% on a beta-blocker, 8.3% on a calcium channel blocker, 43.0% on a diuretic, 27.1% on an aldosterone antagonist, and 16.1% were on digoxin. Out of these patients, 185 patients (31.3%) had atrial fibrillation (AF), and the remaining 68.7% patients were in sinus rhythm.
The commonest cause of HF observed in this study was rheumatic heart disease, which was seen in 148 patients (25.1%). This was followed by dilated cardiomyopathy in 135 patients (22.8%), coronary artery disease in 107 patients (18.1%), non-rheumatic valvular heart disease in 63 patients (10.7%), hypertensive heart disease in 59 patients (10.0%), cor-pulmonale in 38% patients (6.4%), congenital heart disease in 19 patients (3.2%), peripartum cardiomyopathy in 16 patients (2.7%), and hypertrophic cardiomyopathy in 6 patients (1.0%) as shown in Table 2 . When the cause of HF was evaluated according to different age groups, the commonest cause of heart failure in the young age group of ≤44 years was rheumatic heart disease (96 patients, 61.9%), followed by congenital heart disease (17 patients, 11.0%). The commonest cause in the age group from 45 -64 years was dilated cardiomyopathy (56 patients, 29.0%) followed by coronary artery disease (43 patients, 22.3%). This was also true for the older age group of patients ≥ 65 years (26.4% for dilated cardiomyopathy, and 24.3% for coronary artery disease) as shown in 
Mean age of presentation with different causes of HF
When the causes were evaluated according to gender, the commonest cause in males was found to be dilated cardiomyopathy (73 patients, 26.9%) followed by coronary artery disease (71 patients, 26.2%). In females the commonest cause was rheumatic heart disease (101 patients, 31.6%) followed by dilated cardiomyopathy (62 patients, 19.4%) as shown in Table 3 . 
Discussion
HF is a growing cause of hospitalization around the world. With increase in both survival rate and prevalence of coronary artery disease, HF has gained epidemic proportions in developed countries. In developing countries, like Nepal, rheumatic heart disease leading to valvular lesions is still considered as one of the commonest causes of HF admission. Having a prevalence of over 5.8 million in the USA, and over 23 million worldwide, HF is a major public health issue. With a lifetime risk of one in five, HF can originate from CAD, high blood pressure, rheumatic heart disease, or other causes like cardiomyopathies, congenital heart disease, endocarditis and myocarditis. It not only is still a common reason for urgent admission to hospital but also is a major cause of morbidity and mortality. 11 The Everest study demonstrated significant differences in HF severity, etiology, and management among different continents and regions in a large, international trial in acute HF syndromes. Their data demonstrated that despite efforts to select for a fairly homogenous study population, important differences in etiology, severity, management, and outcomes existed. The etiology and management of HF may vary by region and is difficult to control. 14 The mean age of patients presenting with HF in this study was 56.48 ± 19.44, which is consistent with previous reports. In the ADHERE-AP (Asian-Pacific) Study, it was reported that patients registered in South-East Asia were generally younger (median age: 53, 60, 61, 67 and 71 years for Philippines, Indonesia, Malaysia, Thailand and Singapore, respectively) as compared with those in East Asia (median age: 77 years for both Hong Kong and Taiwan) and in Australia (median age: 77 years). 15 Rheumatic heart disease continues to be a major health problem in developing countries (especially Africa and Asia) where it is still an important cause of HF, often in the young. 9 Our The mean age of the patients presenting with coronary artery disease was 65. 14 finding is similar to their study, with an overall 25.1% presenting with HF due to rheumatic heart disease, and increases to 61.9% of the patients when the patients ≤ 44 years were considered. Mendez et al. further noted in their study that, in all countries undergoing epidemiological transition, coronary artery disease is increasingly important as a cause of HF. In our study, the overall frequency of presentation with HF due to coronary artery disease was 18.1%, increasing with age to 22.3% in the patients aged 45 to 64 years, and to 24.3% in patients ≥ 65 years of age. Efforts spent on primary prevention of these conditions may, therefore, result in considerable savings on health care costs considering that the ill-effects of hypertension and rheumatic fever are felt during the productive years of life. 16 The findings of Mendez et al. were also consistent with two studies done in Nepal previously. One study done in Bharatpur, Nepal, showed that the causes of HF were coronary artery disease (36.5%), rheumatic heart disease (25.5%), dilated cardiomyopathy (14.5%), cor-pulmonale (12.2%), hypertensive heart disease (8.6%), and congenital heart disease (2.7%). 11 A study done in the western region of Nepal by Shrestha et al. found that ischemic heart disease (29.5%) was still the commonest cause of HF followed by hypertensive heart disease (24.6%). 12 The effect of the epidemiologic transition varies not only among countries but also among regions, communities or ethnicities in the same country, making it difficult to generalize evidence obtained not only from Western countries but also from Asian countries. Considering the relatively younger age of patients with heart failure and larger population at risk for HF in Asian countries as compared with Western countries, the socioeconomic and clinical effects of heart failure are estimated to be particularly large in Asia. 17 Therefore, further studies to identify the different causes of HF in different regions and ethnicities of Nepal are needed to fully understand the impact of heart failure in the country.
Conclusions
Rheumatic heart disease, dilated cardiomyopathy and coronary artery disease are the commonest causes of HF in our center. Appropriate prevention strategies are required to decrease the burden of HF in Nepal.
